Reddit study maps side effects reported by users of nonapproved retatrutide
Questa scheda è mostrata in inglese finché la sua traduzione non sarà aggiornata.
A cross-sectional study in JAMA Network Open used Reddit posts to identify 13,589 users reporting current use of nonapproved retatrutide between March 2023 and December 2025. Among the 7,823 users with at least one mapped symptom term, the most common were increased appetite (17.1%), fatigue (15.2%), increased energy (12.4%) and nausea (11.6%). Product identity, purity and dose could not be verified, so the study cannot show how often these effects occur or whether retatrutide caused them. The authors describe the findings as hypothesis-generating.